Redwood Investments, LLC Halozyme Therapeutics, Inc. Transaction History

Redwood Investments, LLC

$379 Million
Q1 2024

A detailed history of Redwood Investments, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Redwood Investments, LLC holds 77,306 shares of HALO stock, worth $3.99 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

77,306

Previous 93,050 16.92%

Holding current value

$3.99 Million

Previous $3.44 Million 8.58%

% of portfolio

0.83%

Previous 0.91%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$33.68 - $41.95 $530,257 - $660,460	-15,744 Reduced 16.92%	77,306 $3.14 Million
Q4 2023 Jan 19, 2024	SELL	$33.32 - $42.1 $7.84 Million - $9.91 Million	-235,409 Reduced 71.67%	93,050 $3.44 Million
Q3 2023 Oct 24, 2023	SELL	$36.46 - $44.03 $3.81 Million - $4.6 Million	-104,422 Reduced 24.12%	328,459 $12.5 Million
Q2 2023 Jul 24, 2023	BUY	$30.28 - $38.74 $130,537 - $167,008	4,311 Added 1.01%	432,881 $15.6 Million
Q1 2023 Apr 24, 2023	SELL	$32.86 - $55.7 $435,033 - $737,412	-13,239 Reduced 3.0%	428,570 $16.4 Million

Q4 2022 Jan 20, 2023	SELL	$40.06 - $59.44 $169,854 - $252,025	-4,240 Reduced 0.95%	441,809 $0
Q3 2022 Oct 28, 2022	SELL	$38.53 - $51.78 $3.9 Million - $5.25 Million	-101,332 Reduced 18.51%	446,049 $17.6 Million
Q2 2022 Jul 15, 2022	BUY	$37.35 - $48.3 $6.82 Million - $8.82 Million	182,663 Added 50.08%	547,381 $24.1 Million
Q1 2022 Apr 20, 2022	SELL	$31.97 - $41.06 $69,662 - $89,469	-2,179 Reduced 0.59%	364,718 $14.5 Million
Q4 2021 Feb 03, 2022	SELL	$31.82 - $40.75 $8.05 Million - $10.3 Million	-252,869 Reduced 40.8%	366,897 $14.8 Million
Q3 2021 Oct 19, 2021	BUY	$38.47 - $46.42 $3.12 Million - $3.77 Million	81,110 Added 15.06%	619,766 $25.2 Million
Q2 2021 Aug 02, 2021	SELL	$38.84 - $51.31 $159,554 - $210,781	-4,108 Reduced 0.76%	538,656 $24.5 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $3.52 Million - $4.58 Million	-89,043 Reduced 14.09%	542,764 $22.6 Million
Q4 2020 Feb 05, 2021	BUY	$25.81 - $43.62 $886,057 - $1.5 Million	34,330 Added 5.75%	631,807 $27 Million
Q3 2020 Nov 13, 2020	BUY	$25.74 - $29.63 $3.9 Million - $4.49 Million	151,407 Added 33.94%	597,477 $15.7 Million
Q2 2020 Aug 03, 2020	BUY	$16.25 - $26.81 $7.25 Million - $12 Million	446,070 New	446,070 $12 Million

Others Institutions Holding HALO

# of Institutions

442

Shares Held

122M

Call Options Held

216K

Put Options Held

140K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.18B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.

Account

Redwood Investments, LLC Halozyme Therapeutics, Inc. Transaction History